Found: 25
Select item for more details and to access through your institution.
Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 9, p. 775, doi. 10.1111/j.1463-1326.2011.01414.x
- By:
- Publication type:
- Article
Clinical experience with vildagliptin in the management of type 2 diabetes in a patient population ≥75 years: a pooled analysis from a database of clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 1, p. 55, doi. 10.1111/j.1463-1326.2010.01325.x
- By:
- Publication type:
- Article
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 9, p. 780, doi. 10.1111/j.1463-1326.2010.01233.x
- By:
- Publication type:
- Article
Assessing the cardio–cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 6, p. 485, doi. 10.1111/j.1463-1326.2010.01215.x
- By:
- Publication type:
- Article
Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 8, p. 804, doi. 10.1111/j.1463-1326.2009.01051.x
- By:
- Publication type:
- Article
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 2, p. 157, doi. 10.1111/j.1463-1326.2008.00994.x
- By:
- Publication type:
- Article
Robust improvements in fasting and prandial measures of β-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database.
- Published in:
- Diabetes, Obesity & Metabolism, 2008, v. 10, n. 10, p. 931, doi. 10.1111/j.1463-1326.2007.00835.x
- By:
- Publication type:
- Article
Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study.
- Published in:
- Diabetes, Obesity & Metabolism, 2007, v. 9, n. 2, p. 166, doi. 10.1111/j.1463-1326.2006.00684.x
- By:
- Publication type:
- Article
Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2007, v. 9, n. 2, p. 175, doi. 10.1111/j.1463-1326.2006.00698.x
- By:
- Publication type:
- Article
Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2016, v. 17, n. 1, p. 91, doi. 10.1007/s11154-016-9325-8
- By:
- Publication type:
- Article
Comparison between vildagliptin and metformin to sustain reductions in HbA(1c) over 1 year in drug-naïve patients with Type 2 diabetes.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Comparison between vildagliptin and metformin to sustain reductions in HbA<sub>1c</sub> over 1 year in drug-naïve patients with Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2007, v. 24, n. 9, p. 955, doi. 10.1111/j.1464-5491.2007.02191.x
- By:
- Publication type:
- Article
Octreotide (Long-Acting Release Formulation) Treatment in Patients with Graves’ Orbitopathy: Clinical Results of a Four-Month, Randomized, Placebo-Controlled, Double-Blind Study.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 2, p. 841, doi. 10.1210/jc.2004-1334
- By:
- Publication type:
- Article
A Comprehensive Endocrine Description of Kennedy’s Disease Revealing Androgen Insensitivity Linked to CAG Repeat Length.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 8, p. 3893, doi. 10.1210/jcem.87.8.8780
- By:
- Publication type:
- Article
Sheehan's syndrome: differential diagnosis in the acute phase.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: the ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey.
- Published in:
- International Journal of Clinical Practice, 2006, v. 60, n. 10, p. 1166, doi. 10.1111/j.1742-1241.2006.01124.x
- By:
- Publication type:
- Article
Comparison of vildagliptin and rosiglitazone monotherapy in patients With type 2 diabetes: a 24-week, double-blind, randomized trial.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Vildagliptin was noninferior to rosiglitazone for glycemic control in type 2 diabetes but caused less weight gain.
- Published in:
- ACP Journal Club, 2007, v. 146, n. 3, p. 74
- By:
- Publication type:
- Article
Consistent Efficacy and Safety of Vildagliptin Monotherapy Across Ethnicities.
- Published in:
- Diabetes, 2007, v. 56, p. A543
- By:
- Publication type:
- Article
Robust Efficacy of Vildagliptin in Drug-Naïve Patients: Pooled Analysis of 5 Monotherapy Studies.
- Published in:
- Diabetes, 2007, v. 56, p. A135
- By:
- Publication type:
- Article
Benefit/Risk Assessment of Vildagliptin in the Elderly: Pooled Analysis of 5 Monotherapy Studies.
- Published in:
- Diabetes, 2007, v. 56, p. A135
- By:
- Publication type:
- Article
Achieving Glycemic Goals with Vildagliptin.
- Published in:
- Diabetes, 2007, v. 56, p. A134
- By:
- Publication type:
- Article
Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Smaller LDL particle size in women with polycystic ovary syndrome compared to controls.
- Published in:
- Clinical Endocrinology, 2001, v. 54, n. 4, p. 455, doi. 10.1046/j.1365-2265.2001.01245.x
- By:
- Publication type:
- Article